TrialFrontiers in public health2022

Development and Validation of a Nomogram to Predict Cancer-Specific Survival in Elderly Patients With Papillary Renal Cell Carcinoma.

Chenghao Zhanghuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.